JILL COLES: Open Payments
NPI 1598247694 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 18 payments from 7 companies in 2025. Trend: 2023 $1,000 · 2024 $707 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 1 | $136 |
| ABBVIE INC. | 6 | $127 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $90 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $35 |
| Globus Medical, Inc. | 2 | $32 |
| SPR Therapeutics, Inc | 1 | $18 |
Products named: Evoke, RELISTOR, UBRELVY, BOTOX, JOURNAVX, Senza, QULIPTA, XTAMPZA.
Industry payments across KY — which companies pay providers there.
